B02 RFI Reagent Adapters WRAIR.pdf

PDF 135 KB Posted

Attached to
Reagent Adapters Supplies Federal contract opportunity
Solicitation number
HT942524Q0035
Issued by
Defense Health Agency

About this file

This document is a Request for Information (RFI) issued by the Defense Health Agency (DHA) for Reagent Adapters Supplies. The RFI is seeking information to determine if commercial items exist that can provide the required capabilities for consumables to be used with the Bacterial Disease Branch's Illumina whole genome sequencers at WRAIR.

The key requirements outlined in the RFI include providing a set of 384 full length Y adapter Unique Dual Indexes (UDIs) designed to mitigate index-hopping errors, the ability to provide up to 1536 unique indexes, predesigned GC-balanced and color-balanced adapter sequences, GMP ISO 13485 grade manufacturing practices, and a state-of-the-art synthesis and purification process. Respondents are requested to submit a capabilities statement adhering to the specified format by 10:00 AM ET on April 2, 2024. This RFI is for information and planning purposes only and does not constitute a solicitation.

View the file

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

RFI: PANMRA-23-P 0000 001534

Request for Information (RFI)

Reagent Adapters Supplies

General Information:

This is an RFI as defined in FAR 15.201(e) to ascertain whether a commercial item exists that provides the capabilities described herein.

This RFI is issued solely for information and planning purposes and does not constitute a solicitation. All information received in response to this RFI will be treated as business confidential information. Nonetheless, submitters should properly mark their responses if the information is confidential. Responses to the RFI will not be returned. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expense associated with responding to this RFI.

RFI Response and due date: 2 April 2024

Instructions to Responders:

Responses from all capable and qualified sources are encouraged to respond to this request.

White papers should adhere to the following formatting and outline instructions:

1. All submissions shall be made electronically and be in one of the following formats:

Microsoft Word or Adobe PDF.

2. Cover Page (1page)

• Title

• Organization

• Responders technical and administrative points of contact (names, addresses, phone, fax number and email addresses)

• Topic area(s) addressed

• NAICS Code

• Business Size

• Unique Entity ID

3. Interested parties are asked to respond to this RFI and submit a capabilities statement that supports the focus of this RFI as detailed below. Please review the place of performance requirements. Please submit written responses via email in Microsoft Office 2000 or 2007 format. All responses should be complete: in 12-point font; and not to exceed 3 pages total, including graphics, tables, and appendices.

RFI: PANMRA-23-P 0000 001534

No hardcopies shall be accepted. No written solicitation document is available at this time. Telephone requests will not be honored, and no bidders list shall be maintained.

No inquiries regarding any potential future acquisition activities shall be entertained.

Potential offerors are requested to direct all questions via email to the Point of Contact listed below. Responses are due to the Point of Contact, Mr. Nathaniel Reus at email:

nathaniel.a.reus.civ@health.mil no later than 10:00AM ET, Tuesday, 2 April 2024.

Requirement & Specification: This requirement is to purchase the necessary consumables for the Illumina whole genome sequencers owned by the Bacterial Disease Branch’s (BDB) at WRAIR. The consumables will include a set of 384 TruSeq- Compatiable Duplex full length Y adapters.

Minimum Essential Characteristics (MEC)

Reagent Adapters Supplies

Consumables for use in Whole Genome Sequencers to be delivered under this contract shall meet the following minimum essential characteristics:

• Contractor shall provide a set of 384 full length Y adapter Unique Dual Indexes (UDIs) designed to mitigate errors introduced by index-hopping.

• Contractor shall have the ability to provide a multiplex capacity of up to 1536 unique indexes.

• Contractor shall have available predesigned sequences balanced to prevent GC bias and color-balanced for 2- and 4-color Illumina sequencers.

• Contractor shall have the ability to implement GMP ISO 13485 grade adapter manufacturing practices for clinical research applications.

• Contractor shall implement a manufacturing process that uses state-of-the-art synthesis, purification methods, designed specifically for NGS adapters.

• Contractor shall perform quality control, such as a functional NGS testing, on each new batch of stocked adapter and indexing primer products to ensure the new batch of adapters and primers produce sequencing libraries that meet MRSN sequencing requirements.

Request for Information (RFI)

File details come from the government source that posted it. Updated .